# reload+after+2024-01-22 03:44:08.903809
address1§2100 West Loop South
address2§Suite 900
city§Houston
state§TX
zip§77027
country§United States
phone§800 946 9185
website§https://www.cnspharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc., Reata Pharmaceuticals, Inc., Pomeranian Medical University, and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was incorporated in 2017 and is based in Houston, Texas.
fullTimeEmployees§3
companyOfficers§[{'maxAge': 1, 'name': 'Mr. John Michael Climaco Esq., J.D.', 'age': 54, 'title': 'CEO, President & Director', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 813750, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Christopher S. Downs CPA, CTP, FP&A', 'age': 45, 'title': 'Chief Financial Officer', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 476000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Sandra L. Silberman M.D., Ph.D.', 'age': 68, 'title': 'Chief Medical Officer', 'yearBorn': 1955, 'fiscalYear': 2022, 'totalPay': 280000, 'exercisedValue': 0, 'unexercisedValue': 2625}, {'maxAge': 1, 'name': 'Dr. Waldemar  Priebe Ph.D.', 'title': 'Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Donald H. Picker Ph.D.', 'age': 77, 'title': 'Chief Science Officer', 'yearBorn': 1946, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.03
currency§USD
dateShortInterest§1702598400
forwardEps§-12.0
exchange§NCM
quoteType§EQUITY
shortName§CNS Pharmaceuticals, Inc.
longName§CNS Pharmaceuticals, Inc.
firstTradeDateEpochUtc§1573223400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§d5944f40-c6d8-36ac-a359-a17d6936eb31
gmtOffSetMilliseconds§-18000000
recommendationMean§3.0
recommendationKey§hold
quickRatio§0.224
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
